Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Citius Oncology Stock News

CTORNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Citius Oncology (CTOR) Forecast

News

Earnings Citius Oncology (CTOR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Citius Oncology Stock News | NASDAQ:CTOR | Benzinga

Get the latest news on Citius Oncology stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Citius Oncology performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, May 27, 2025

This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor

Friday, May 23, 2025

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Avi Kapoor
Maxim Group Downgrades Citius Oncology to Hol...
Benzinga Newsdesk

Wednesday, May 14, 2025

Citius Oncology Q2 EPS $(0.11) Misses $(0.09)...
Benzinga Newsdesk

Monday, May 05, 2025

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Friday, April 25, 2025

Citius Oncology Receives Nasdaq Notice For B...
Benzinga Newsdesk

Wednesday, April 23, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Friday, April 11, 2025

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Wednesday, April 02, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Tuesday, April 01, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Monday, March 31, 2025

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Wednesday, March 26, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights

Monday, March 24, 2025

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Tuesday, March 18, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Monday, March 17, 2025

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Friday, February 14, 2025

Citius Oncology Q1 2025 GAAP EPS $(1.30) Miss...
Benzinga Newsdesk

Thursday, February 06, 2025

Citius Pharma Announces LYMPHIR Is Approved B...
Benzinga Newsdesk

Tuesday, January 07, 2025

Citius Pharmaceuticals And Citius Oncology An...
Benzinga Newsdesk

Monday, January 06, 2025

Citius Oncology To Explore Strategic Alternat...
Benzinga Newsdesk

Monday, December 30, 2024

Reported Friday, Citius Oncology FY 2024 GAAP...
Benzinga Newsdesk

Tuesday, December 03, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Wednesday, November 27, 2024

Maxim Group Initiates Coverage On Citius Onco...
Benzinga Newsdesk

Monday, November 11, 2024

Citius Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Citius Pharmaceuticals And Citius Oncology Re...
Benzinga Newsdesk

Wednesday, October 30, 2024

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Friday, October 25, 2024

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Monday, October 21, 2024

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Friday, September 13, 2024

Dr. Reddy's Laboratories Agreed To Partially ...
Benzinga Newsdesk

Thursday, September 05, 2024

Citius Pharmaceuticals' LYMPHIR Added To NCCN...
Benzinga Newsdesk

Tuesday, August 13, 2024

Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
EF Hutton Maintains Buy on Citius Oncology, M...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved